Guardian Pharmacy Services, Inc. Class A (GRDN)
NYSE:GRDN
Want to see GRDN full AI Analyst Report?
Earnings Data
Report Date
Aug 17, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.26Last Year’s EPS
0.23Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a positive operational and financial outturn for Q1 2026: the company successfully navigated major IRA-driven disruption, delivered revenue resilience, strong gross profit and adjusted EBITDA growth, and raised adjusted EBITDA guidance. Key risks remain, including a severe (~60%) branded pricing decline caused by the IRA, temporary working capital and payment-timing stresses, margin pressure from recent acquisitions (~80 bps drag), and potential cost headwinds from fuel and labor. Management emphasized scale advantages, proactive payor negotiations, and confidence in normalization of working capital, while noting that certain quarter-specific benefits are non-recurring. On balance, highlights demonstrating execution and financial strength outweigh the lowlights tied mainly to one-time disruptions and ongoing cost/legislative uncertainty.Company Guidance
Revenue Resilience Despite IRA Impact
Reported revenue of $336.6 million for Q1 2026, up 2% year-over-year. Management estimates that absent the government-mandated IRA price declines revenues would have grown by low double digits year-over-year.
Strong Gross Profit Performance
Gross profit of $76.0 million, up 19% year-over-year (up 14% excluding a $3 million discrete benefit). Reported gross margin was 22.7% (22.0% excluding the $3 million benefit), reflecting successful mitigation actions with payors.
Adjusted EBITDA Growth and Guidance Raise
Adjusted EBITDA of $29.8 million, up 27% year-over-year with an adjusted EBITDA margin of 8.8% (14% growth and 8.0% margin excluding the $3 million discrete benefit). Company updated full-year adjusted EBITDA guidance to $123 million–$127 million (up from $120 million–$124 million) to reflect the $3 million pass-through benefit; revenue guidance remains $1.40 billion–$1.42 billion.
Healthy Volume Trends
Total residents increased ~10% year-over-year to ~207,000 at quarter end; script volumes also increased ~10% year-over-year, supporting organic growth and enrollment dynamics (assisted living ~70% of mix).
Balance Sheet and Cash Position
Cash of $65 million at quarter end (essentially flat vs. year-end), minimal debt, strong operating cash flow covering Q1 seasonal items and a temporary working capital shift related to IRA. Company remains focused on M&A and greenfield investments as capital priorities.
Successful Operational Transition Under IRA
Company completed first full quarter operating under the IRA framework, navigated new transaction/process complexities (including Medicare Transaction Facilitator flows and varied manufacturer data formats), maintained service levels and customer relationships, and asserted ability to forecast and execute in the new environment.
Nondilutive Secondary Offering Completed
Completed a secondary offering of 6.9 million Class A shares (including full overallotment) at $31 per share, enhancing liquidity and broadening the investor base while fully utilizing prior S-3 capacity; new shelf registration filed for flexibility.
Tax and EPS Metrics
Effective tax rate of 26% (in line with expectations) and adjusted EPS of $0.29 for the quarter.
Guardian Pharmacy Services, Inc. Class A (GRDN) Earnings, Revenues Date & History
GRDN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GRDN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $36.58 | $36.27 | -0.85% |
Mar 11, 2026 | $33.51 | $33.27 | -0.72% |
Nov 10, 2025 | $29.75 | $31.25 | +5.04% |
Aug 11, 2025 | $19.88 | $22.62 | +13.78% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Guardian Pharmacy Services, Inc. Class A (GRDN) report earnings?
Guardian Pharmacy Services, Inc. Class A (GRDN) is schdueled to report earning on Aug 17, 2026, After Close (Confirmed).
What is Guardian Pharmacy Services, Inc. Class A (GRDN) earnings time?
Guardian Pharmacy Services, Inc. Class A (GRDN) earnings time is at Aug 17, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GRDN EPS forecast?
GRDN EPS forecast for the fiscal quarter 2026 (Q2) is 0.26.